| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 105 | 2022 |
| Leveraging large language models for decision support in personalized oncology M Benary, XD Wang, M Schmidt, D Soll, G Hilfenhaus, M Nassir, C Sigler, ... JAMA Network Open 6 (11), e2343689-e2343689, 2023 | 43 | 2023 |
| Comparative analysis of public knowledge bases for precision oncology S Pallarz, M Benary, M Lamping, D Rieke, J Starlinger, C Sers, ... JCO Precision Oncology 3, 1-8, 2019 | 36 | 2019 |
| Support of a molecular tumour board by an evidence-based decision management system for precision oncology M Lamping, M Benary, S Leyvraz, C Messerschmidt, E Blanc, T Kessler, ... European Journal of Cancer 127, 41-51, 2020 | 32 | 2020 |
| How cyanobacteria pose new problems to old methods: challenges in microarray time series analysis R Lehmann, R Machné, J Georg, M Benary, IM Axmann, R Steuer BMC bioinformatics 14, 1-16, 2013 | 30 | 2013 |
| Disentangling pro-mitotic signaling during cell cycle progression using time-resolved single-cell imaging M Benary, S Bohn, M Lüthen, IK Nolis, N Blüthgen, A Loewer Cell reports 31 (2), 2020 | 17 | 2020 |
| IL-2 Expression in Activated Human Memory FOXP3+ Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors of T Cell … H Bendfeldt, M Benary, T Scheel, K Steinbrink, A Radbruch, H Herzel, ... Frontiers in Immunology 3, 264, 2012 | 15 | 2012 |
| Stable IL-2 decision making by endogenous c-Fos amounts in peripheral memory T-helper cells H Bendfeldt, M Benary, T Scheel, S Frischbutter, A Abajyan, A Radbruch, ... Journal of Biological Chemistry 287 (22), 18386-18397, 2012 | 15 | 2012 |
| Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards DT Rieke, T de Bortoli, P Horak, M Lamping, M Benary, I Jelas, G Rüter, ... BMC medicine 20 (1), 367, 2022 | 9 | 2022 |
| Prediction of regulatory transcription factors in T helper cell differentiation and maintenance YH Lee, M Benary, R Baumgrass, H Herzel Genome Informatics 2009: Genome Informatics Series Vol. 22, 84-94, 2010 | 9 | 2010 |
| Modeling IL-2 gene expression in human regulatory T cells M Benary, H Bendfeldt, R Baumgrass, H Herzel Genome Informatics 20, 222-230, 2008 | 5 | 2008 |
| Creation of a structured molecular genomics report for Germany as a local adaption of HL7’s Genomic Reporting Implementation Guide C Stellmach, J Sass, B Auber, M Boeker, T Wienker, AJ Heidel, M Benary, ... Journal of the American Medical Informatics Association 30 (6), 1179-1189, 2023 | 3 | 2023 |
| Information flow in a mammalian signal transduction pathway M Benary, I Nolis, N Blüthgen, A Loewer Information-and Communication Theory in Molecular Biology, 101-114, 2017 | 2 | 2017 |
| preon: Fast and accurate entity normalization for drug names and cancer types in precision oncology A Ermshaus, M Piechotta, G Rüter, U Keilholz, U Leser, M Benary Bioinformatics 40 (3), btae085, 2024 | 1 | 2024 |
| Tumour mutational burden and survival with molecularly matched therapy T de Bortoli, M Benary, P Horak, M Lamping, S Stintzing, I Tinhofer, ... European Journal of Cancer 190, 112925, 2023 | 1 | 2023 |
| The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities E Ramberger, V Sapozhnikova, YLD Ng, A Dolnik, M Ziehm, O Popp, ... Nature cancer, 1-18, 2024 | | 2024 |
| A diagnostic challenge of KIT p. V559D and BRAF p. G469A mutations in a paragastric mass S Habringer, J Ihlow, K Kleo, A Klostermann, M Schmidt, L Chai, ... The Oncologist, oyae137, 2024 | | 2024 |
| 144P Artificial intelligence supported treatment decisions for precision oncology DT Rieke, X Wang, M Schmidt, D Soll, G Hilfenhaus, M Nassir, C Sigler, ... Annals of Oncology 34, S238, 2023 | | 2023 |
| S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA E Ramberger, A Dolnik, YLD Ng, M Ziehm, O Popp, E Sträng, M Kull, ... HemaSphere 7 (S3), e4765105, 2023 | | 2023 |
| Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts. DT Rieke, T de Bortoli, M Benary, P Horak, M Lamping, S Stintzing, ... Journal of Clinical Oncology 41 (16_suppl), 3066-3066, 2023 | | 2023 |
